Saddle Nose Deformity

1. Executive Overview: Understanding Saddle Nose Deformity

Saddle nose deformity, clinically classified under ICD-10 code M95.0 (Acquired deformity of nose), represents a complex structural compromise of the nasal dorsum. Morphologically, it is characterized by a "saddle-like" depression of the nasal bridge, resulting from the loss of structural support of the cartilaginous or bony nasal vault.

From a clinical perspective, this condition is rarely a primary diagnosis; rather, it is typically a sequela of an underlying inflammatory, traumatic, or iatrogenic process. The loss of the L-strut—the structural framework consisting of the dorsal and caudal septum—leads to the collapse of the nasal profile. While often perceived as a cosmetic concern, saddle nose deformity frequently manifests with significant functional impairment, including nasal valve collapse, airway obstruction, and chronic rhinitis. Effective management requires a multidisciplinary approach, often involving otolaryngologists, plastic surgeons, and rheumatologists, depending on the underlying etiology.

2. Pathophysiology, Etiology, and Risk Factors

The nasal bridge relies on the structural integrity of the cartilaginous septum and the underlying bony framework. When this framework is compromised, the skin and soft tissue envelope collapse inward.

Etiology and Classification

The causes of saddle nose deformity are broadly categorized into four primary domains:

Pathophysiological Mechanism

In autoimmune conditions like GPA, the pathophysiology involves necrotizing vasculitis that targets the cartilaginous tissue. The inflammatory process triggers the release of proteases and collagenases, which degrade the extracellular matrix of the septal cartilage. Once the support is lost, the nasal dorsum loses its projection, leading to the classic "saddle" appearance. In iatrogenic cases, the removal of excessive cartilage during surgery weakens the structural "L-strut," which eventually buckles under the pressure of the overlying soft tissues.

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation varies based on the severity of the structural collapse. Early signs often involve nasal congestion, while advanced cases present with obvious facial dysmorphology.

Common Clinical Findings:

• Visual Dorsal Depression: A visible dip in the nasal bridge between the bony radix and the nasal tip.
• Nasal Valve Collapse: As the support structure weakens, the internal and external nasal valves may collapse during inspiration, leading to severe airway resistance.
• Columellar Retraction: In severe cases, the retraction of the caudal septum causes the nasal tip to rotate cephalad (upward), creating a "pig-snout" appearance.
• Mucosal Crusts: Often seen in cases of autoimmune or substance-induced destruction, accompanied by chronic epistaxis (nosebleeds) and purulent discharge.

4. Standard Diagnostic Evaluation & Workup

A systematic diagnostic approach is mandatory to determine whether the deformity is stable (post-traumatic) or progressive (autoimmune/infectious).

Diagnostic Framework

1. Clinical Examination: Anterior rhinoscopy and nasoendoscopy to assess the integrity of the septal mucosa and the degree of cartilaginous loss.
2. Imaging (Gold Standard):
   • Computed Tomography (CT) without contrast: The gold standard for evaluating the bony and cartilaginous architecture. It identifies the extent of the septal defect and the status of the paranasal sinuses.
   • MRI: Utilized if soft tissue malignancy or invasive inflammatory processes are suspected.
3. Laboratory Assays: Essential for ruling out systemic vasculitis.
   • ANCA (Anti-neutrophil cytoplasmic antibody): Highly sensitive for Granulomatosis with Polyangiitis.
   • ESR/CRP: Elevated markers of chronic inflammation.
   • Syphilis Serology (RPR/VDRL): Mandatory in cases of sudden septal perforation.
4. Biopsy: If the mucosa appears granular or necrotic, a biopsy of the septal tissue is required to rule out malignancy or granulomatous disease.

5. Therapeutic Interventions

Management is strictly dictated by the stability of the disease process. Surgical reconstruction must never be performed during an active autoimmune or infectious phase.

Pharmacotherapy

• Autoimmune Management: Corticosteroids, cyclophosphamide, or rituximab are used to achieve clinical remission of the underlying disease before any surgical intervention is considered.
• Supportive Care: Topical saline irrigation and antibiotic ointments to manage crusting and prevent secondary infection.

Surgical Reconstruction

Surgical repair aims to restore structural support and aesthetic projection using autologous grafts.

• Autologous Cartilage Grafts: The gold standard. Rib cartilage (costal cartilage) is typically harvested to provide the necessary volume and structural rigidity to rebuild the L-strut.
• Ear Cartilage Grafts: Used for minor deformities or as an overlay graft.
• Alloplastic Implants: Generally avoided due to high rates of infection, extrusion, and rejection in the nasal environment, particularly in patients with a history of autoimmune destruction.

Lifestyle and Long-term Prognosis

Patients must be advised to avoid nasal irritants, specifically cocaine, which can cause rapid and catastrophic recurrence of the deformity. Long-term prognosis is excellent if the underlying systemic condition is controlled. Patients should expect a staged approach, with medical stabilization followed by definitive reconstructive surgery.

6. Frequently Asked Questions (FAQ)

1. Is saddle nose deformity purely a cosmetic issue?
No. While the aesthetic change is significant, the primary clinical concern is the functional loss of nasal breathing due to valve collapse and airway obstruction.

2. Can saddle nose be treated without surgery?
In cases of minor deformity, temporary fillers may be used; however, these do not address the structural collapse. Definitive treatment for functional improvement requires surgical reconstruction.

3. Why is rib cartilage used for reconstruction?
Rib cartilage provides the necessary volume and structural strength required to support the nasal dorsum, which is often unavailable in sufficient quantities in the septum or ear.

4. How long do I need to wait for surgery if I have an autoimmune disease?
The disease must be in clinical remission, typically confirmed by stable lab markers (ANCA) and no evidence of mucosal inflammation for at least 6–12 months.

5. Does insurance cover the repair of a saddle nose?
In many jurisdictions, if the surgery is documented as a functional reconstruction to correct airway obstruction, it is often covered as a medically necessary procedure.

6. Will my nose look exactly as it did before?
Reconstruction aims to restore significant projection and structural integrity, but it is a complex procedure. Expectations should be managed with your surgeon regarding the final aesthetic outcome.

7. Are there risks to using silicone implants?
Yes. Silicone and other synthetic implants carry a high risk of extrusion and infection in the nose, which is why autologous tissue is preferred.

8. Is saddle nose deformity hereditary?
No, it is an acquired condition resulting from trauma, surgery, or systemic disease.

9. What is the role of the rheumatologist in my care?
If your saddle nose is caused by an autoimmune condition, your rheumatologist is crucial in managing your systemic health to prevent further destruction of cartilage.

10. How long is the recovery period after reconstructive surgery?
Recovery usually involves a nasal splint for 1–2 weeks, with significant swelling resolving over 3–6 months. Full stabilization of the reconstructed framework can take up to a year.